Oncogenic drivers are identified through various genomic techniques, including:
Next-generation sequencing (NGS): A high-throughput method that allows for the rapid sequencing of large stretches of DNA, identifying mutations that may be driving cancer. Whole-exome sequencing: Focuses on sequencing the protein-coding regions of the genome to find mutations in genes that might be involved in cancer. Whole-genome sequencing: Provides a comprehensive view of the entire genome, identifying both coding and non-coding mutations.